Cytotoxic granular protein expression, epstein-barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T- lymphocyte/natural killer cell lymphomas from Mexico

Modern Pathology

Volumn 11, Issue 8, 1998, Pages 754-761

  Elenitoba Johnson, Kojo S J ^a,d   Zarate Osorno, Alexandra ^b,c   Meneses, Abelardo ^b,c   Krenacs, Laszlo ^a,e   Kingma, Douglas W ^a   Raffeld, Mark ^a   Jaffe, Elaine S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c Hospital Central Militar   (Mexico)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Epstein Barr virus; Latent membrane protein; Nasal lymphoma

Indexed keywords

CYTOTOXIC FACTOR; PERFORIN; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOMA; MALE; MEXICO; NATURAL KILLER CELL; NOSE; ONCOGENE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; FEMALE; GENE DELETION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MEXICO; MIDDLE AGED; NOSE NEOPLASMS; POLY(A)-BINDING PROTEINS; POLYMERASE CHAIN REACTION; PORE FORMING CYTOTOXIC PROTEINS; PROTEINS; RNA-BINDING PROTEINS; VIRAL MATRIX PROTEINS;

EID: 0031856984     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Chan JKC, Ng C, Lau W, Ho STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-29.
2. Ho FC, Choy D, Loke S, Kung I, Fu K, Liang R, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases and immunophenotypic studies of 16 cases. Hum Pathol 1990;21:1041-50.
3. Jaffe ES, Chan JKC, Su IJ, Frizzera G, Mori S, Feller AC, et al. Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11.
4. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-9.
5. Gaulard P, Henni T, Marolleau J-P, Haioun C, Henni Z, Voisin M-C, et al. Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis: evidence for a monoclonal T-cell lymphoproliferative disorder. Cancer 1988;62:705-10.
6. Kanavaros P, Lescs M-C, Briere J, Divine M, Galateau F, Joab I, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-95.
7. Emile JF, Boullard M-L, Haioun C, Kanavaros P, Petrella T, Delfau-Larue M-H, et al. CD5-/CD56+ T-cell receptor: silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996;87:1466-73.
8. Chiang AK, Srivastava G, Lau PW, Ho FC. Differences in T-cell receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications for cellular origin. Hum Pathol 1996;27:701-7.
9. Chiang AK, Chan AC, Srivastava G, Ho FC. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer 1997;73:332-8.
10. Liu C, Walsh CM, Young JD. Perforin: structure and function. Immunol Today 1995;16:194-201.
11. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991;67:629-39.
12. Weiss LM, Arber DA, Strickler JG. Nasal T-cell lymphoma. Ann Oncol 1994;5(Suppl 1):39-42.
13. Kieff E, Liebowitz D. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, editors. Virology. 2nd ed. New York: Raven Press; 1990. p. 1889-920.
14. Frank D, Cesarman E, Liu YF, Michler Re, Knowles DM. Post-transplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995;85:1396-403.
15. Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, et al. Expression of B-type Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 1993;78:3004-11.
16. Gratama IW, Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 1995;67:197-255.
17. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
18. Peng M, Lundgren E. Transient expression of the Epstein-Barr virus LMP-1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 1992;7: 1775-82.
19. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane-1 protects infected B cells from programmed cell death. Cell 1991;65:1107-15.
20. Chen ML, Tsai CN, Liang CL, Shu CH, Hang CR, Sulizeanu D, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992;7:2131-40.
21. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, et al. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993;82:2937-42.
22. Sandvej K, Peh S-C, Andresen BS, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994;84:4053-60.
23. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. EBV LMP-1 oncogene deletions: correlations with malignancy in EBV-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996;88:242-51.
24. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christenson B, et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein, LMP-1. Oncogene 1993;8:1575-83.
25. Young JDE, Hengartner H, Podack ER, Cohn AA. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 1986;44:849-59.
26. Griffiths GM, Mueller C. Expression of perform and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991;12:415-9.
27. Anderson P. TIA-1: structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 1995;198:131-43.
28. Kingma DW, Medeiros LJ, Barletta J, Raffeld M, Mann RB, Ambinder RF, et al. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 1994;18:48-61.
29. McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedermann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor γ chain gene. Diagn Mol Pathol 1992;1:173-9.
30. Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995;16: 202-6.
31. Darmon AJ, Nicholson DW, Bleackley RC. Activation of apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995;377:446-8.
32. Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, et al. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990;144:574-82.
33. Lanier LL, Cwirla S, Federspiel N. Human natural killer cells isolated from peripheral blood do not rearrange T-cell antigen receptor β chain genes. J Exp Med 1986;163:209-14.
34. Borisch B, Finke J, Hennig I, Delcretaz F, Schneider J, Heitz PU, et al. Distribution and localization of Epstein-Barr virus subtypes A and B: AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 1992;168:229-36.
35. Young LS, Yao QY, Roponey CM, Sculley TB, Moss DJ, Rupani H, et al. New type isolate of Epstein-Barr virus from Burkitt's lymphoma and normal individuals in endemic areas. J Gen Virol 1987;63:2853-62.
36. Chen W-G, Chen Y-Y, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996;148:17-23.
37. Burrows JM, Khanna R, Sculley TB, Alpers MP, Moss DJ, Burrows SR. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J Virol 1996;70:4829-33.
38. Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in post-transplant lymphoproliferative disorders. Lab Invest 1996;75:575-88.
39. Khanim F, Yao Q-Y, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996;88:3491-501.